205 related articles for article (PubMed ID: 33024904)
1. Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: The basis of better selection of atherosclerosis treatment.
Chen Y; Zeng Y; Zhu X; Miao L; Liang X; Duan J; Li H; Tian X; Pang L; Wei Y; Yang J
Bioact Mater; 2021 Mar; 6(3):880-889. PubMed ID: 33024904
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and mechanism of local delivery of rapamycin and rapamycin-loaded poly(lactic-co-glycolic) acid nanoparticles on coronary restenosis of injury-stenosis model of minipigs].
Miao LF; Yin YP; Cui YL; Chen LF; Zeng Y; Huang CL; Zhu WL; Song CX; Zhang H; She MP; Yang J
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(1):36-42. PubMed ID: 26792606
[TBL] [Abstract][Full Text] [Related]
3. Bilayered Nanoparticles with Sequential Release of VEGF Gene and Paclitaxel for Restenosis Inhibition in Atherosclerosis.
Zhu X; Xie H; Liang X; Li X; Duan J; Chen Y; Yang Z; Liu C; Wang C; Zhang H; Fang Q; Sun H; Li C; Li Y; Wang C; Song C; Zeng Y; Yang J
ACS Appl Mater Interfaces; 2017 Aug; 9(33):27522-27532. PubMed ID: 28748694
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Inhibitory Effect of the Double-layer Nano-infusion on Vascular Restenosis in Animal Models of Coronary Atherosclerosis.
Cao G; Kang H; Yu H; He Q
Cell Mol Biol (Noisy-le-grand); 2022 Mar; 68(3):314-321. PubMed ID: 35988184
[TBL] [Abstract][Full Text] [Related]
7. pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis.
Zhu H; Kong L; Zhu X; Ran T; Ji X
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335910
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor 1alpha (HIF-1alpha) correlated with tumor growth and apoptosis in ovarian cancer.
Jiang H; Feng Y
Int J Gynecol Cancer; 2006; 16 Suppl 1():405-12. PubMed ID: 16515634
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Rapamycin and Rapamycin-loaded Poly(lactic-co-glycolic)Acid Nanoparticles on Apoptosis and Expression of bcl-2 and p27(kip1) Proteins of Human Umbilical Arterial Vascular Smooth Muscle Cell].
Miao LF; Cui YL; Yin YP; Chen LF; Zhang H; Liu PM; Zhu WL; Song CX; Yang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):633-40. PubMed ID: 26725384
[TBL] [Abstract][Full Text] [Related]
10. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
[TBL] [Abstract][Full Text] [Related]
11. [Effect of opening of mitochondrial ATP-sensitive K(+) channels on the expression of hypoxia inducible factor-1alpha and cell proliferation in pulmonary arterial smooth muscle cells of rats].
Zhao JP; Guo Z; Zhou ZG; Chen J; Hu HL; Wang T; Zhang ZX
Sheng Li Xue Bao; 2007 Apr; 59(2):157-62. PubMed ID: 17437037
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of hypoxia-inducible factor 1alpha expression and tumor growth in SKOV3 ovarian cancer model by sirolimus].
Jiang HY; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):474-7. PubMed ID: 15347472
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
14. Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
Sheehy A; Hsu S; Bouchard A; Lema P; Savard C; Guy LG; Tai J; Polyakov I
Cardiovasc Diabetol; 2012 Jun; 11():75. PubMed ID: 22716997
[TBL] [Abstract][Full Text] [Related]
15. Euonymine inhibits in-stent restenosis through enhancing contractile phenotype of vascular smooth muscle cells via modulating the PTEN/AKT/mTOR signaling pathway.
Zhang L; Tao Y; Yang R; Hu Q; Jia J; Yu M; He B; Shen Z; Qin H; Yu Z; Chen P
Phytomedicine; 2022 Dec; 107():154450. PubMed ID: 36174454
[TBL] [Abstract][Full Text] [Related]
16. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent.
Yang J; Zeng Y; Zhang C; Chen YX; Yang Z; Li Y; Leng X; Kong D; Wei XQ; Sun HF; Song CX
Biomaterials; 2013 Feb; 34(6):1635-43. PubMed ID: 23199742
[TBL] [Abstract][Full Text] [Related]
17. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
[TBL] [Abstract][Full Text] [Related]
18. [Effects of rapamycin-loaded poly(lactic-co-glycolic) acid nanoparticles on distribution of cell cycle, expression of p27 protein, and proliferation of human umbilical arterial vascular smooth muscle cell in vitro].
Miao LF; Huang CL; Chen LF; Zhu WL; Yang J; Wang YG; Zhang H; Liu PM; She MP; Song CX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):32-8. PubMed ID: 20236585
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin and Paclitaxel Affect Human Aortic Smooth Muscle Cells-Derived Foam Cells Viability and Proliferation.
Kang Y; Cai Y; Pan W
Braz J Cardiovasc Surg; 2022 May; 37(2):200-206. PubMed ID: 34236783
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
